KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBT: 2009-2025

Historic EBT for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -$17.8 million.

  • Exact Sciences' EBT rose 52.56% to -$17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$994.8 million, marking a year-over-year decrease of 372.42%. This contributed to the annual value of -$1.0 billion for FY2024, which is 413.60% down from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' EBT is -$17.8 million, which was down 31,052.63% from -$57,000 recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' EBT registered a high of $1.0 million during Q3 2023, and its lowest value of -$876.0 million during Q4 2024.
  • In the last 3 years, Exact Sciences' EBT had a median value of -$50.4 million in 2023 and averaged -$123.3 million.
  • As far as peak fluctuations go, Exact Sciences' EBT surged by 100.69% in 2023, and later plummeted by 3,688.49% in 2024.
  • Over the past 5 years, Exact Sciences' EBT (Quarterly) stood at -$224.9 million in 2021, then skyrocketed by 42.22% to -$129.9 million in 2022, then soared by 61.23% to -$50.4 million in 2023, then slumped by 1,638.86% to -$876.0 million in 2024, then spiked by 52.56% to -$17.8 million in 2025.
  • Its EBT stands at -$17.8 million for Q3 2025, versus -$57,000 for Q2 2025 and -$101.0 million for Q1 2025.